Real-time enrollment status for this breast cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT05514054 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 8,000 participants |
| Active Locations | 139 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | January 29, 2026 (Jan 29, 2026) |
As of March 2, 2026: Clinical trial NCT05514054 is currently active_not_recruiting participants. This clinical trial study for breast cancer is not currently accepting new participants at 139 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05514054 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 139 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05514054 was last updated Jan 29, 2026 (January 29, 2026). HelloStudys verifies this status automatically.